GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness
Open accessThe DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Abstract
Glycogen synthase kinase 3β (GSK3β), originally described as a negative regulator of glycogen synthesis, is a molecular hub linking numerous signaling pathways in a cell. Specific GSK3β inhibitors have anti-depressant effects and reduce depressive-like behavior in animal models of depression. Therefore, GSK3β is suggested to be engaged in the pathogenesis of major depressive disorder, and to be a target and/or modifier of anti-depressants’ action. In this review, we discuss abnormalities in the activity of GSK3β and its upstream regulators in different brain regions during depressive episodes. Additionally, putative role(s) of GSK3β in the pathogenesis of depression and the influence of anti-depressants on GSK3β activity are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Treatment with GSK-3β inhibitors reduces the production of QUIN and subsequently alleviates depressive, anxious, and aggressive behaviors in animal models (137).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [137]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, post-mortem studies have reported elevated GSK-3β mRNA levels in the hippocampus of patients with major depression.”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [137]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · cited 1×
“Systemic injection of pro-inflammatory cytokines induces depression-like phenotype [132].”
BackgroundWnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583 · cited 1×
“β-catenin, a multifunctional protein downstream to WNT signaling [112], is another factor putatively regulating stress resilience development [113].”
BackgroundInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 1×
“Both of these pathways reduce the activity of GSK3β, but only PI3K/AKT acts through phosphorylation of Ser9 [92,93].”
BackgroundMalhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
AKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492 · cited 1×
“These findings resulted in the monoaminergic hypothesis of the MDD pathogenesis, which assumes that MDD is caused by a reduction in noradrenaline (NA) and serotonin (5-HT) neurotransmission [4].”
BackgroundSubgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693 · cited 1×
“In 1997, a reduction in the cortical volume of patients suffering from different types of depression was linked to decreased brain activity [74].”
BackgroundGut–brain axis: How the microbiome influences anxiety and depression
Foster, J. A., & McVey Neufeld, K.-A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.005 · Cited by 2,460 · cited 1×
“It is worth noting that multiple research groups have reported that the manipulation of the gastrointestinal tract microbiome status affects anxiety- and depressive-like behaviors in rodents, and that the administration of probiotics reduces such behaviors [151].”
BackgroundKrishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 1×
“It corresponds to results of post mortem studies of human brains where an increased level of BDNF in nucleus accumbens has been detected [90].”
ResultA molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 2×
“The discovery that GSK3β is a direct target of lithium action [63] has raised the possibility that lithium exerts its effects through the odulating activity of the kinase.”
Background
Cited by
Hassamal, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130989 · Cited by 578
Molecular pathways of major depressive disorder converge on the synapse
Fries, G. R., Saldana, V. A., Finnstein, J., & Rein, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01806-1 · Cited by 504
“Polyamines such as spermidine, spermine, putrescine and agmatine are short, aliphatic amines that impact several pathways and synaptic activity by a variety of mechanisms; the impacted molecules and pathways include almost all systems mentioned in this review, e.g., Na+-, K+- and Ca2+-channels, 5-HT, NMDA, AMPA, kaina…”
BackgroundXiao, Z., Cao, Z., Yang, J., Jia, Z., Du, Y., Sun, G., Lu, Y. F., & Pei, L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114594 · Cited by 76
Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases
Marosi, M., Arman, P., Aceto, G., D’Ascenzo, M., & Laezza, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084413 · Cited by 46
“Herein, we provide an overview of the mechanisms by which GSK3β mediates direct and indirect effects on Nav and Kv channels with implications for neuronal excitability, plasticity, and ultimately vulnerability to neuropsychiatric disorders [34,53,56,58,59].”
BackgroundUrkon, M., Ferencz, E., Szász, J. A., Szabó, M. I. M., Orbán-Kis, K., Szatmári, S., & Nagy, E. E. (2025) · Pharmaceuticals · doi:10.3390/ph18050614 · Cited by 45
“In addition, enhanced BDNF signaling or TNF α reduction could also contribute to Akt/GSK-3 β regulation [185].”
Chaperone Sigma1R and Antidepressant Effect
Воронин, М. В., Vakhitova, Y. V., & Середенин, С. Б. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197088 · Cited by 44
Shi, J.-X., Cheng, C., Ruan, H.-N., Li, J., & Liu, C. (2023) · NeuroToxicology · doi:10.1016/j.neuro.2023.06.007 · Cited by 36
Transcriptomic decoding of regional cortical vulnerability to major depressive disorder
Zhu, J., Chen, X., Lu, B., Li, X.-Y., Wang, Z., Cao, L., Chen, G., Chen, J.-S., Chen, T., Chen, T.-L., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06665-w · Cited by 40
“This ,andtoactasanemergingtargetand/ormodi fi er of antidepressants ’ action 106,107 .”
Su, Q., Li, T., Li, T., Zhang, Y., Guo, J., Wang, Z.-J., Wu, M.-N., & Qi, J.-S. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.353479 · Cited by 33
“…expression in the prefrontal cortex and hippocampus (Yucel et al., 2016; Lu et al., 2018), and activate the extracellular signal-regulated kinase-protein kinase B-glycogen synthase kinase 3β (ERK-AKT-GSK3β) signaling pathway (Duda et al., 2020), which can help to ameliorate the depressive disorder.”
BackgroundChakraborti, A., Graham, C., Chehade, S. B., Vashi, B., Umfress, A., Kurup, P. K., Vickers, B. N., Chen, H. A., Telange, R., Berryhill, T. F., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.669410 · Cited by 30
LTBP1 plays a potential bridge between depressive disorder and glioblastoma
Fu, X., Zhang, P., Song, H., Wu, C., Li, S., Li, S., & Yan, C. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02509-3 · Cited by 23
Tsimberidou, A. M., Skliris, A., Valentine, A. D., Shaw, J. V., Hering, U., Vo, H. H., Chan, T. O., Armen, R. S., Cottrell, J. R., Pan, J. Q., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00793-8 · Cited by 23
Zhang, T., Yang, C., Chu, J., Ning, L., Zeng, P. H., Wang, X., Shi, Y., Qin, B., Qu, N., Zhang, Q., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.696619 · Cited by 22
Role of Semaphorin 3A in common psychiatric illnesses such as schizophrenia, depression, and anxiety
Yang, Y., Guan, W., Sheng, X.-M., & Gu, H. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116358 · Cited by 23
Alzarea, E. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alexiou, A. T., Papadakis, M., Beshay, O. N., & Batiha, G. E. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08832-6 · Cited by 23
“The GSK3β is the most common type of GSK3, highly expressed in the brain (Duda et al., 2020; Engel et al., 2018) and is intricate in the regulation of synaptic plasticity and neurogenesis through phosphoinositide 3-kinase/AKT and Wnt/β-catenin signaling pathways (Y. Wang et al., 2021; Zheng et al.,…”
Wang, C., & Ming-qi, G. (2023) · Neurochemical Research · doi:10.1007/s11064-023-04026-3 · Cited by 22
“Studies have shown that GSK3β is associated with the development of depression [77] and that inhibition of GSK3 activity produces antidepressant effects associated with neurogenesis [78].”
Elmalky, M. I., Álvarez-Bolado, G., Younsi, A., & Skutella, T. (2024) · Biology · doi:10.3390/biology13090703 · Cited by 24
Kalkman, H. O. (2023) · Biomedicines · doi:10.3390/biomedicines11030806 · Cited by 18
“The serine/threonine kinase glycogen-synthase kinase 3 (GSK3) acts as a master switch between, on the one hand, a pro-inflammatory/pro-oxidative and, on the other hand, a proliferative, protective, and restorative biological program [14,15].”
BackgroundGlycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression
McCallum, R. T., & Perreault, M. L. (2021) · Cells · doi:10.3390/cells10092270 · Cited by 21
Tian, J., Wu, Z.-N., Wu, D., Yang, C., Gao, Y., Yan, D.-L., & Qin, X. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01312-5 · Cited by 17
“A large number of experiments suggest that factors influencing the BDNF level in the brain also impact GSK-3β activity (Mai et al. 2002; Duda et al. 2020 ).”
BackgroundNandi, N. K., Bhatia, R., Saini, S., Rawat, R., Sharma, S., Raj, K., Rangra, N. K., & Kumar, B. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.134671 · Cited by 15
Rosso, G., Maina, G., Teobaldi, E., Balbo, I., Salvo, G. D., Montarolo, F., Pesci, N. R., Tempia, F., & Hoxha, E. (2023) · International Journal of Bipolar Disorders · doi:10.1186/s40345-023-00314-7 · Cited by 17
“Second, in most studies patients were not free from other drugs such as benzodiazepines, antidepressants or mood stabilizers, that are known to affect GSK3 expression (Duda et al. 2020).”
BackgroundMechanisms of nucleus accumbens deep brain stimulation in treating mental disorders
Ruan, H., Tong, G., Jin, M., Koch, K., & Wang, Z. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.06.009 · Cited by 14
Jung, S., Kim, Y., Kim, M., Seo, M., Kim, S., Kim, S. J., & Lee, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158203 · Cited by 16
Sun, W., Lu, Z., Chen, X., Yang, Mei, Y., Li, X., & An, L. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00383 · Cited by 13
Xu, F., Wu, H., Xie, L., Chen, Q., Xu, Q., Sun, L., Li, H., Xie, J., & Chen, X. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1109458 · Cited by 13
“…that active GSK3β is strongly associated with the downscaling of synapses, declined neuronal excitability and increased inflammatory response (Duda et al., 2020), so we speculate that the increased GSK3β activity may be involved in PPD by affecting neuroplasticity and neuroinflammation.”
BackgroundBączyńska, E., Zaręba-Kozioł, M., Ruszczycki, B., Krzystyniak, A., Wójtowicz, T., Bijata, K., Pochwat, B., Magnowska, M., Roszkowska, M., Figiel, I., et al. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100683 · Cited by 10
“In - summary, we conclude that resilient behavior is accompanied by structural compensation in the hippocampus, which is shown in the representative confocal images of dendritic spines in Figure 5E. l P”
Lotfi, G., Eslami, M., Gholami, M., Vaseghi, S., & Yekta, B. G. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04753-4 · Cited by 13
“Evidence has shown that specific GSK-3β inhibitors have immunomodulatory effects and can attenuate depressive-like behaviors in animal models [25].”
Molecular Mechanisms of Emerging Antidepressant Strategies: From Ketamine to Neuromodulation
Kowalczyk, M., Aebisher, D., Szpara, J., Czech, S., Bartusik‐Aebisher, D., & Henrykowska, G. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010344 · Cited by 11
Lee, Y., Bortolotto, Z. A., Bradley, C. A., Sanderson, T. M., Zhuo, M., Kaang, B., & Collingridge, G. L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.804130 · Cited by 15
“Considering GSK-3 inhibitors are effective in mouse models of depression (Beaulieu et al., 2009; Jope, 2011; Duda et al., 2020), and have anxiolytic effects in MWM (Nguyen et al., 2017), it is possible that CT99021 is alleviating behavioral stress in the MWM allowing employment of more thoughtful…”
BackgroundMolecular Mechanism for PACAP 38-Induced Neurite Outgrowth in PC12 Cells
Shibato, J., Takenoya, F., Hirabayashi, T., Kimura, A., Yamashita, M., Takasaki, I., Rakwal, R., & Shioda, S. (2021) · Neural Plasticity · doi:10.1155/2021/2522454 · Cited by 9
Mechanism of saikogenin G against major depressive disorder determined by network pharmacology
Hu, L., Wang, J., Zhao, X., & Cai, D. (2022) · Medicine · doi:10.1097/md.0000000000030193 · Cited by 8
Hsu, C., Zeng, J., Chen, L., Chen, L., Li, X., Yang, J.-Z., Liu, Y., Liu, J.-L., Li, J.-H., Li, J.-H., et al. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117173 · Cited by 7
Why is lithium effective in alleviating bipolar disorder?
Sato, K. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110484 · Cited by 9
The Effects of Brain Serotonin Deficiency on Responses to High Fat Diet in Female Mice
Huq, S. N., Warner, A. K., Buckhaults, K., & Sachs, B. D. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.683103 · Cited by 7
“, 2007, 2012), have led to the hypothesis that GSK3β is a critical player in the development of major depression that also plays an important role in antidepressant treatment responses (Duda et al., 2020).”
BackgroundWang, Y., Deng, Y., Feng, M., Chen, J., Zhong, M., Han, Z., Zhang, Q., & Sun, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119249 · Cited by 10
Chronic Unpredictable Mild Stress in Rats based on the Mongolian medicine
Xin, H., Su, S., Wu, R., Wei, L., Su, N., Qi, L., Wu, R., Ruhan, A., Tong, L., Wang, W., et al. (2023) · Journal of Visualized Experiments · doi:10.3791/65889 · Cited by 7
Wang, Z., Cheng, Y., Lu, Y. F., Sun, G., & Pei, L. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b21-01046 · Cited by 6
Kaufman, M. J., & Meloni, E. G. (2025) · Medical Gas Research · doi:10.4103/mgr.medgasres-d-24-00063 · Cited by 4
Hao, S., Chen, X., Zhang, D., Song, W., Zhou, Y., Yuan, Z., Liu, Z., Yue, X., & Yuan, S. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13723 · Cited by 4
Presenilin‐2 knock‐In mice show severe depressive behavior via DVL3 downregulation
Yoo, S. S., Lee, D. W., Ham, H. J., Yeo, I. J., Chang, J. Y., Yun, J., Son, D. J., Han, S., & Hong, J. T. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14370 · Cited by 5
“21 24 Like AD, GSK3 β is associated with depression.”
BackgroundGSK3β Activity in Reward Circuit Functioning and Addiction
Turlik, J., Wąsikiewicz, E., Domaradzka, A., Chrostek, G., Gniadzik, W., Domagalski, M., & Duda, P. (2021) · NeuroSci · doi:10.3390/neurosci2040033 · Cited by 4
“The inhibitors may be useful in therapies for the aforementioned affective disorders, in which GSK3β is dysregulated [57].”
BackgroundSelf-citationYan, X., Song, X., Chen, W., Jia, Y., Gao, J., Wang, X., Qin, L., Xue, R., & Song, G. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175996 · Cited by 5
Creatine prevents ouabain-induced manic-like behavior by modulating GSK-3β via PI3K/AKT/mTOR pathway
Souza-Pereira, A., Guerra, J. M. D. S., Nieswald, B. H., Maidana, L. M., Correa, A. B., Godinho, D. B., Royes, L. F. F., & Rambo, L. M. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174115 · Cited by 6
Gong, X.-N., Zhou, Y.-X., Wang, C.-Y., Wang, T.-T., Gao, Z.-Y., Long, W.-C., Li, R., & Cai, L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.116065 · Cited by 3
Chi-Wei, L., Wu, H.-F., Yen, H.-J., Lun-De, L., Mao, W.-C., Chang, H., Chen, Y., Lin, C.-H., Li, C.-T., & Lin, H.-C. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05638-2 · Cited by 4
“In addition, previous studies have shown that stress-induced LTP impairment was followed by GSK3β activation [25–27].”
Medicinal Plants for Major Depressive Disorder
Bertollo, A. G., Spohr, L., BEARZI, A. E., Kreuz, K. M., & Ignácio, Z. M. (2026) · Brain Sciences · doi:10.3390/brainsci16020223 · Cited by 4
“While increased activity of this kinase in the PFC has been associated with MDD pathogenesis and the reduction in synapse size and neuronal excitability, its inhibition, facilitated by the BDNF/Akt pathway, is fundamental for the induction of long-term potentiation (LTP) and neuronal survival [176].”
Hamdon, S., Fernandez-Gonzalez, P., Omar, M. Y., González-Sepúlveda, M., Ortiz, J., & Gil, C. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109759 · Cited by 5
Milasauskiene, E., Burkauskas, J., Jesmanas, S., Gleiznienė, R., Borutaitė, V., Škėmienė, K., Vaitkienė, P., Adomaitienė, V., Lukoševičius, S., Gradauskienė, B., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311218 · Cited by 3
Johannessen, K., Braný, D., Dvorská, D., Krivošová, M., Oppa, M., Ondrejka, I., Strnádel, J., Ferencová, N., Tonhajzerová, I., Daňková, Z., et al. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101108 · Cited by 4
LncRNA RNCR3 Promotes the Progression of HCC by Activating the Akt/GSK3β Signaling Pathway
Xie, Q., Ju, T.-F., Zhou, C., & Zhai, L. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8367454 · Cited by 3
“+e activation of Akt depends on the phosphorylation of +r308 and Ser473 and the activated Akt can inactivate GSK-3 by phosphorylating a single residue on GSK3β Ser9 [17].”
BackgroundRouhani, M., & Hadi‐Alijanvand, H. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00952 · Cited by 3
Zhang, S., Chen, Q., Wu, L., Sun, K., Lan, X., Xie, X., & Yan, J. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/5750647 · Cited by 3
“Specific GSK-3β inhibitors are endowed with antidepressant effects, and they are able to alleviate the depression-like behavior in those animal models with depression [37].”
BackgroundRetractedDiabetes-induced depression: unravelling the role of gut dysbiosis
Sharma, V. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01643-3 · Cited by 3
“Its regulation involves phosphorylation at Tyr216 (activation) and Ser9 (inhibition) [139 ].”
Wu, J., Zhu, C., Shu, Y., Lu, Y., Liu, L., Xiao, Z., & Li, Z. (2025) · Psychiatry Investigation · doi:10.30773/pi.2025.0091 · Cited by 2
“23 Researches regarding GSK-3β not only demonstrate GSK-3β plays its regulatory effect on oxidative pathway, 7,24 but also plays critical roles in physiological synaptic plasticity and aberrant GSK-3β activity contributes to the development of dysfunctional synaptic plasticity in neuropsychiatric…”
Adibian, S., Dehghani, E., Dalil-Housh, Z., Motamedi-Manesh, A., Moradi, H., Hajizamani, S., & Vaseghi, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05353-y · Cited by 2
“GSK-3β is a part of numerous cellular signaling pathways and several kinases, phosphatases, and proteases regulate its function [132].”
Nagasubramanian, K., & Gupta, K. K. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2023.2279502 · Cited by 3
Chen, B. K., Whye, A., Matthews, L. C., Moniz, T., Mendez‐David, I., Gardier, A. M., David, D. J. P., Johns, S., Weisblum, E., & Denny, C. A. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02107-1 · Cited by 3
Jeon, Y., & Kim, J. H. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07152-0 · Cited by 2
“Abbreviations: OR: odds ratio, CI: confidence interval, HbA1c: glycated haemoglobin observed in both depressed patients and animal models, and IL-1β is known to suppress neurogenesis, GLP1R agonism may mitigate depressive symptoms through modulation of inflammatory pathways [38, 39].”
Nalepa, I., Chorążka, K., Kreiner, G., Zelek-Molik, A., Haduch, A., Daniel, W. A., Chmielarz, P., Maziarz, K., Kuśmierczyk, J., Wilczkowski, M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110488 · Cited by 2
Chen, C., Feng, L., Shi, P., Liu, Q., Zhang, L.-W., Wang, Q., Hua, R., Su, X., & Li, W. (2025) · Behavioral and Brain Functions · doi:10.1186/s12993-025-00305-x · Cited by 1
Tapia‐González, S., Yagüe, J. G., & Barreto, G. E. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.12.023 · Cited by 2
Rupanagunta, G. P., Patra, J., Upadhyay, J., Nandave, M., & Ansari, M. N. (2026) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-026-01989-2 · Cited by 2
“For example, PTGS2 and GSK3β influence mood regulation [23, 24], while PPARγ modulates neuroinflammation and neurosteroid synthesis [25].”
Navigating the Complexity: A Comprehensive Review of GSK‐3 Inhibition in Regenerative Medicine
Schiroli, D., Merra, A., Marraccini, C., Merolle, L., Pellegrini, G., & Maurizi, E. (2026) · Medicinal Research Reviews · doi:10.1002/med.70095 · Cited by 1
Exploring the Relationship between Gut Microbiota and Major Depressive Disorders
Tian, C. (2021) · E3S Web of Conferences · doi:10.1051/e3sconf/202127103055 · Cited by 1
Adri, A. S., Nóbile, A. L., de Alburquerque, D. G., Barcelos, P. M., do Vale, F. Y. N., Bahia, I. A. F., Freire, P. P., Nava, R. G., Corrêa, Y. L. G., Cabral‐Miranda, G., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.13.623441 · Cited by 4
Intracellular signaling cascades in bipolar disorder
Vecera, C. M., Jones, G. H., Chong, A. C., Ruiz, A. C., Rong, C., Soares, J. C., & Machado‐Vieira, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821398-8.00029-1
The Neuroanatomy, Etiopathogenesis, and Novel Therapeutic Targets in Depressive Disorders
Arora, I., Khurana, K., & Kumar, M. (2024) · Current Psychopharmacologye · doi:10.2174/0122115560281804240102054639
Role of long non-coding RNAs in depression: Mechanisms and potential therapeutic targets
Ding, Z., Shen, J., Wei, C., Liu, Z., Huang, L., & Zhou, S. (2024) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2024.100142
Sofla, M. A. M., Gholami, M., Vaseghi, S., Barikrow, N., & Yekta, B. G. (2025) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000842 · Cited by 2
Joshi, N., Modi, A., Samantaray, S., Vasa, S., Shibu, S., Jadeja, Y., Chaudhari, R., Trivima, S., & Parekh, B. (2025) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-025-00842-w
Neurensin-2 is a negative regulator of CB1 receptor
Ghanem, Y. A., Dorfman-Yahad, L., Hovav, H. C., Agbariya, L., Cohen, A., Yehuda, H., & Umschweif, G. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117382
Adri, A. S., Nóbile, A. L., de Albuquerque, D. G., Barcelos, P. M., do Vale, F. Y. N., Nava, R. G., Corrêa, Y. L. G., Schimke, L. F., Onuchic², L. F., Dalmolin, R. J. S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-39284-y
“Furthermore, the diseasome network analysis revealed associations of these seven shared genes with various psychiatric and physiological conditions, including mood disorders 38–40 , autoimmune diseases 71 , and cardiovascular issues 72–75 .”
Li, N., Feng, Y., Gong, Q., Duan, H., Yan, H., Zhang, H., Wang, C., & Liu, Z. (2026) · Neurobiology of Stress · doi:10.1016/j.ynstr.2026.100791
Luo, J., Luo, J., Huang, Y., Lei, Q., Wu, Y., Han, B., & Xu, B. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c17741
Abdulla, Z. I., Garcia-Milian, R., Giahyue, E., Fertuzinhos, S., Collin, F., Wang, W., Lam, T. T., Nairn, A. C., & Picciotto, M. R. (2026) · eNeuro · doi:10.1523/eneuro.0030-26.2026
“GSK3A and GSK3B have mechanistic links to antidepressant ef fi cacy: both are inhibited by lithium (used to treat bipolar disorder), and alterations in their activity and concentration are linked to prodepressive phenotypes in preclinical studies (Beurel et al., 2015; Duda et al., 2020).”
Singh, P., Ambaliya, S. V., Kumar, G. S., Yadav, S. S., & Datusalia, A. K. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05916-7
Depression, Immune Mechanisms, and Anti-inflammatory Treatment Strategies
Loftis, J. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-14465-2_24
Chaihu-Shugan San modulates hippocampal 5-HT2A and BDNF in PSD rats
Jia, K., Feng, L., & Qian, L. (2026) · The European Zoological Journal · doi:10.1080/24750263.2026.2666501 · Cited by 1
Al‐kuraishy, H. M., Abass, S. A., Mahana, H. A. M., Elbanna, O. A., Shahin, I., Radwan, A. A., MohamedMohamed, O. E.-S., Baktoot, A. M. L., & Batiha, G. E. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12110-4 · Cited by 1
“Loss of this inhibitory control facilitates GSK-3β overactivation, thereby enhancing apoptotic and inflam - matory signaling pathways [46].”
InfluentialDalil-Housh, Z., Niakani, A.-H., Jalalian-Javadpour, M., Poode, Z. H., Sepehri, L., Javid, R., & Vaseghi, S. (2026) · Behavioural Neurology · doi:10.1155/bn/8686305
“GSK-3 β participates in numerous cellular signaling cascades, and its activity is both directly and indirectly controlled by a variety of kinases, phosphatases, and proteases [102].”
Zhou, J., Zhu, C., Li, J., 杜来玲, Yuan, J., Tian, K., Zhang, X., & Li, X. (2026) · Health Science Reports · doi:10.1002/hsr2.73030
“When specific GSK3β inhibitors are used, a certain degree of antidepressant effect will be produced [40, 41], and an increase in GSK3α/β protein levels and an increase in GSK3β activity can be detected in peripheral blood cells of BD patients [42], suggesting that high levels of GSK3β may promote…”
Grad, M., Volkov, H., & Shomron, N. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02597-8
“Gsk3β is also a serine/threonine kinase and a master regulator of multiple signaling pathways, such as transcription, mitochondrial function, and cytoskeleton maintenance, making it critical for sustainment of cell homeostasis (Duda et al. 2020).”
Abbas, K., Alam, M., Usmani, N., & Habib, S. (2026) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-026-00891-4
“…2012) and the concomitant hyperactivation of the Glycogen Synthase Kinase 3 beta/ Nuclear Factor kappa-light-chain-enhancer of activated B cells (GSK-3β/NF-κB) axis promotes a pro-inflammatory state that exacerbates oxidative stress and apoptotic signalling (Duda et al. 2020; Teresa et al. 2022).”
Metadata
- Authors
- Duda, P., Hajka, D., Wójcicka, O., Rakus, D., & Gizak, A.
- Affiliations
- University of Wrocław (PL)
- Corresponding author
- Duda, Przemysław
- Gizak, Agnieszka
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-03-16
- Volume
- 9
- Issue
- 3
- Pages
- 727
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7140610
- OpenAlex
- W3012493302
- Cited by
- 84
- References
- 211
- Citations by year
- 2026: 15 · 2025: 20 · 2024: 11 · 2023: 12 · 2022: 12 · 2021: 11 · 2020: 3
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Polish Ministry of Science and Higher Education (UMO-2015/19/B/NZ1/00332)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- GSK3β, glycogen synthase kinase-3β, major depressive disorder, depression pathogenesis, antidepressant response, GSK-3β inhibitors, antidepressant mechanism, upstream regulators, brain regions, depression-like behavior
- MeSH terms
- Neuroprotection, Glycogen Synthase Kinase 3 beta, Animals, Brain, Major Depressive Disorder, Hippocampus, Humans, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.